力生制药：深入推进原料药与制剂一体化发展

Core Viewpoint - The company is focusing on integrating raw material and formulation development to reduce production costs and mitigate the impact of price reductions from centralized procurement [1] Group 1: Company Strategy - The company is advancing the integration of raw materials and formulations to lower production costs [1] - By independently developing raw materials, the company aims to buffer the impact of price cuts from centralized procurement [1] - The company is actively expanding its sales coverage both in breadth and depth [1] Group 2: Market Expansion - For products that have won centralized procurement bids, the company leverages its brand advantage and sales network to increase distribution in grassroots medical facilities and retail pharmacies [1] - The company is striving to enhance market penetration and increase sales volume through diverse channel expansion [1]